226 related articles for article (PubMed ID: 36975179)
1. The phenotype of the most common human ADAR1p150 Zα mutation P193A in mice is partially penetrant.
Liang Z; Chalk AM; Taylor S; Goradia A; Heraud-Farlow JE; Walkley CR
EMBO Rep; 2023 May; 24(5):e55835. PubMed ID: 36975179
[TBL] [Abstract][Full Text] [Related]
2. ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing.
Guo X; Liu S; Sheng Y; Zenati M; Billiar T; Herbert A; Wang Q
Cell Rep; 2023 Jul; 42(7):112733. PubMed ID: 37421629
[TBL] [Abstract][Full Text] [Related]
3. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
Nakahama T; Kawahara Y
Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
Nakahama T; Kawahara Y
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
[TBL] [Abstract][Full Text] [Related]
6. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself.
Liddicoat BJ; Piskol R; Chalk AM; Ramaswami G; Higuchi M; Hartner JC; Li JB; Seeburg PH; Walkley CR
Science; 2015 Sep; 349(6252):1115-20. PubMed ID: 26275108
[TBL] [Abstract][Full Text] [Related]
7. The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms.
Kleinova R; Rajendra V; Leuchtenberger AF; Lo Giudice C; Vesely C; Kapoor U; Tanzer A; Derdak S; Picardi E; Jantsch MF
Nucleic Acids Res; 2023 May; 51(9):4191-4207. PubMed ID: 37026479
[TBL] [Abstract][Full Text] [Related]
8. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
[TBL] [Abstract][Full Text] [Related]
9. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
[TBL] [Abstract][Full Text] [Related]
10. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
[TBL] [Abstract][Full Text] [Related]
11. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis.
Heraud-Farlow JE; Chalk AM; Linder SE; Li Q; Taylor S; White JM; Pang L; Liddicoat BJ; Gupte A; Li JB; Walkley CR
Genome Biol; 2017 Sep; 18(1):166. PubMed ID: 28874170
[TBL] [Abstract][Full Text] [Related]
12. ADAR1 averts fatal type I interferon induction by ZBP1.
Jiao H; Wachsmuth L; Wolf S; Lohmann J; Nagata M; Kaya GG; Oikonomou N; Kondylis V; Rogg M; Diebold M; Tröder SE; Zevnik B; Prinz M; Schell C; Young GR; Kassiotis G; Pasparakis M
Nature; 2022 Jul; 607(7920):776-783. PubMed ID: 35859176
[TBL] [Abstract][Full Text] [Related]
13. Generation of a new
Liang Z; Goradia A; Walkley CR; Heraud-Farlow JE
RNA; 2023 Sep; 29(9):1325-1338. PubMed ID: 37290963
[TBL] [Abstract][Full Text] [Related]
14. ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation.
Hu SB; Heraud-Farlow J; Sun T; Liang Z; Goradia A; Taylor S; Walkley CR; Li JB
Mol Cell; 2023 Nov; 83(21):3869-3884.e7. PubMed ID: 37797622
[TBL] [Abstract][Full Text] [Related]
15. Cell death following the loss of ADAR1 mediated A-to-I RNA editing is not effected by the intrinsic apoptosis pathway.
Walkley CR; Kile BT
Cell Death Dis; 2019 Dec; 10(12):913. PubMed ID: 31801951
[TBL] [Abstract][Full Text] [Related]
16. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
[TBL] [Abstract][Full Text] [Related]
17. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.
de Reuver R; Verdonck S; Dierick E; Nemegeer J; Hessmann E; Ahmad S; Jans M; Blancke G; Van Nieuwerburgh F; Botzki A; Vereecke L; van Loo G; Declercq W; Hur S; Vandenabeele P; Maelfait J
Nature; 2022 Jul; 607(7920):784-789. PubMed ID: 35859175
[TBL] [Abstract][Full Text] [Related]
18. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
[TBL] [Abstract][Full Text] [Related]
19. Differential Structural Features of Two Mutant ADAR1p150 Zα Domains Associated with Aicardi-Goutières Syndrome.
Langeberg CJ; Nichols PJ; Henen MA; Vicens Q; Vögeli B
J Mol Biol; 2023 Apr; 435(8):168040. PubMed ID: 36889460
[TBL] [Abstract][Full Text] [Related]
20. ADAR1 entraps sinister cellular dsRNAs, thresholding antiviral responses.
Keegan LP; Vukić D; O'Connell MA
Trends Immunol; 2021 Nov; 42(11):953-955. PubMed ID: 34642093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]